Hedge Fund - Knoll Capital Management
Biohaven Pharmaceutical Holding Co Ltd. (BHVN)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $19,974,331 | 12.99% | 830,879 | $35.26 |
| 2 | 2024 - Q4 (2024-12-31) | $28,401,761 | 18.28% | 760,422 | $46.66 |
| 3 | 2024 - Q3 (2024-09-30) | $35,499,787 | 16.45% | 710,422 | $38.91 |
| 4 | 2024 - Q2 (2024-06-30) | $24,658,747 | 16.61% | 710,422 | $39.54 |
| 5 | 2024 - Q1 (2024-03-31) | $26,821,179 | 16.68% | 490,422 | $49.52 |
| 6 | 2023 - Q4 (2023-12-31) | $20,990,061 | 17.38% | 490,422 | $31.10 |
| 7 | 2023 - Q3 (2023-09-30) | $12,755,876 | 13.24% | 490,422 | $20.78 |
| 8 | 2023 - Q2 (2023-06-30) | $10,774,092 | 13.06% | 450,422 | $17.21 |
| 9 | 2023 - Q1 (2023-03-31) | $6,152,764 | 9.48% | 450,422 | $15.92 |
| 10 | 2022 - Q4 (2022-12-31) | $6,251,857 | 14.1% | 450,422 | $14.12 |
| 11 | 2022 - Q3 (2022-09-30) | $136,181,000 | 79.57% | 900,844 | $7.42 |
| 12 | 2022 - Q2 (2022-06-30) | $131,406,000 | 75% | 900,844 | $127.74 |
| 13 | 2022 - Q1 (2022-03-31) | $106,813,000 | 67.03% | 900,844 | $124.72 |
| 14 | 2021 - Q4 (2021-12-31) | $123,594,000 | 67.91% | 896,844 | $127.16 |
| 15 | 2021 - Q3 (2021-09-30) | $119,024,000 | 59.35% | 856,844 | $124.86 |
| 16 | 2021 - Q2 (2021-06-30) | $83,182,000 | 43.43% | 856,844 | $81.16 |
| 17 | 2021 - Q1 (2021-03-31) | $58,565,000 | 38.15% | 856,844 | $80.88 |
| 18 | 2020 - Q4 (2020-12-31) | $73,496,000 | 50.1% | 857,494 | $84.74 |
| 19 | 2020 - Q3 (2020-09-30) | $55,746,000 | 45.68% | 857,494 | $65.54 |
| 20 | 2020 - Q2 (2020-06-30) | $62,074,000 | 35.83% | 857,494 | $53.22 |
| 21 | 2020 - Q1 (2020-03-31) | $29,181,000 | 27.41% | 857,494 | $45.72 |
| 22 | 2019 - Q4 (2019-12-31) | $46,631,000 | 34.43% | 857,494 | $49.52 |
| 23 | 2019 - Q3 (2019-09-30) | $35,775,000 | 32.74% | 857,494 | $42.25 |
| 24 | 2019 - Q2 (2019-06-30) | $32,834,000 | 26.87% | 749,815 | $56.37 |
| 25 | 2019 - Q1 (2019-03-31) | $38,593,000 | 29.32% | 749,815 | $43.20 |
| 26 | 2018 - Q4 (2018-12-31) | $27,728,000 | 31.54% | 749,815 | $36.05 |
| 27 | 2018 - Q3 (2018-09-30) | $27,916,000 | 23.59% | 749,815 | $36.78 |
| 28 | 2018 - Q2 (2018-06-30) | $29,633,000 | 25.18% | 749,815 | $31.73 |
| 29 | 2018 - Q1 (2018-03-31) | $19,315,000 | 19.83% | 749,815 | $29.90 |
| 30 | 2017 - Q4 (2017-12-31) | $21,779,000 | 19.19% | 807,224 | $27.53 |
| 31 | 2017 - Q3 (2017-09-30) | $30,150,000 | 25.78% | 807,224 | $30.33 |
| 32 | 2017 - Q2 (2017-06-30) | $20,181,000 | 26.75% | 807,224 | $23.03 |
The displayed share prices are average quarterly stock market prices.